These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22129577)

  • 41. Correction of a urea cycle defect after ex vivo gene editing of human hepatocytes.
    Zabulica M; Srinivasan RC; Akcakaya P; Allegri G; Bestas B; Firth M; Hammarstedt C; Jakobsson T; Jakobsson T; Ellis E; Jorns C; Makris G; Scherer T; Rimann N; van Zuydam NR; Gramignoli R; Forslöw A; Engberg S; Maresca M; Rooyackers O; Thöny B; Häberle J; Rosen B; Strom SC
    Mol Ther; 2021 May; 29(5):1903-1917. PubMed ID: 33484963
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Developing adenoviral-mediated in vivo gene therapy for ornithine transcarbamylase deficiency.
    Raper SE; Wilson JM; Yudkoff M; Robinson MB; Ye X; Batshaw ML
    J Inherit Metab Dis; 1998; 21 Suppl 1():119-37. PubMed ID: 9686350
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and mutation analysis of 24 Chinese patients with ornithine transcarbamylase deficiency.
    Shao Y; Jiang M; Lin Y; Mei H; Zhang W; Cai Y; Su X; Hu H; Li X; Liu L
    Clin Genet; 2017 Sep; 92(3):318-322. PubMed ID: 28266016
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A simple screening method for heterozygous female patients with ornithine transcarbamylase deficiency.
    Iijima H; Kubota M
    Mol Genet Metab; 2022 Nov; 137(3):301-307. PubMed ID: 36252454
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fatal clinical course of ornithine transcarbamylase deficiency in an adult heterozygous female patient.
    Heringlake S; Böker K; Manns M
    Digestion; 1997; 58(1):83-6. PubMed ID: 9018015
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Analysis of clinical features, biochemical analysis and gene mutations in one Chinese pedigree with neonatal-onset ornithine transcarbamylase deficiency].
    Sun WH; Yang Y; Zhang YP; Li XT; Zhang M; Cao Y; Wang Y
    Zhonghua Er Ke Za Zhi; 2011 May; 49(5):356-60. PubMed ID: 21624287
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-frequency detection of deletions and variable rearrangements at the ornithine transcarbamylase (OTC) locus by oligonucleotide array CGH.
    Shchelochkov OA; Li FY; Geraghty MT; Gallagher RC; Van Hove JL; Lichter-Konecki U; Fernhoff PM; Copeland S; Reimschisel T; Cederbaum S; Lee B; Chinault AC; Wong LJ
    Mol Genet Metab; 2009 Mar; 96(3):97-105. PubMed ID: 19138872
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Complete recovery from acute encephalopathy of late-onset ornithine transcarbamylase deficiency in a 3-year-old boy.
    Mak CM; Siu TS; Lam CW; Chan GC; Poon GW; Wong KY; Low LC; Tang NL; Li SK; Lau KY; Kwong NS; Tam S
    J Inherit Metab Dis; 2007 Nov; 30(6):981. PubMed ID: 17922216
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A case with combined rare inborn metabolic disorders: congenital adrenal hyperplasia and ornithine transcarbamylase deficiency.
    Kim YM; Lee BH; Choi JH; Kim GH; Lim HH; Yoo HW
    Gene; 2013 Sep; 527(1):394-6. PubMed ID: 23769969
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hyperammonemic coma in an ornithine transcarbamylase mutation carrier following antepartum corticosteroids.
    Lipskind S; Loanzon S; Simi E; Ouyang DW
    J Perinatol; 2011 Oct; 31(10):682-4. PubMed ID: 21956151
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Are asymptomatic carriers of OTC deficiency always asymptomatic? A multicentric retrospective study of risk using the UCDC longitudinal study database.
    Sen K; Izem R; Long Y; Jiang J; Konczal LL; McCarter RJ; ; Gropman AL; Bedoyan JK
    Mol Genet Genomic Med; 2024 Apr; 12(4):e2443. PubMed ID: 38634223
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term correction of ammonia metabolism and prolonged survival in ornithine transcarbamylase-deficient mice following liver-directed treatment with adeno-associated viral vectors.
    Moscioni D; Morizono H; McCarter RJ; Stern A; Cabrera-Luque J; Hoang A; Sanmiguel J; Wu D; Bell P; Gao GP; Raper SE; Wilson JM; Batshaw ML
    Mol Ther; 2006 Jul; 14(1):25-33. PubMed ID: 16677864
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sustained correction of OTC deficiency in spf( ash) mice using optimized self-complementary AAV2/8 vectors.
    Wang L; Wang H; Morizono H; Bell P; Jones D; Lin J; McMenamin D; Yu H; Batshaw ML; Wilson JM
    Gene Ther; 2012 Apr; 19(4):404-10. PubMed ID: 21850052
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urea cycle disorders-update.
    Matsumoto S; Häberle J; Kido J; Mitsubuchi H; Endo F; Nakamura K
    J Hum Genet; 2019 Sep; 64(9):833-847. PubMed ID: 31110235
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recapitulation of Skewed X-Inactivation in Female Ornithine Transcarbamylase-Deficient Primary Human Hepatocytes in the FRG Mouse: A Novel System for Developing Epigenetic Therapies.
    Cunningham SC; van Dijk EB; Zhu E; Sugden M; Mandwie M; Siew S; Devanapalli B; Tolun AA; Klein A; Wilson L; Aryamanesh N; Gissen P; Baruteau J; Bhattacharya K; Alexander IE
    Hum Gene Ther; 2023 Sep; 34(17-18):917-926. PubMed ID: 37350098
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lymphocyte mRNA analysis of the ornithine transcarbamylase gene in Italian OTCD male patients and manifesting carriers: identification of novel mutations.
    Giorgi M; Morrone A; Donati MA; Ciani F; Bardelli T; Biasucci G; Zammarchi E
    Hum Mutat; 2000 Apr; 15(4):380-1. PubMed ID: 10737985
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Investigating neurological deficits in carriers and affected patients with ornithine transcarbamylase deficiency.
    Sprouse C; King J; Helman G; Pacheco-Colón I; Shattuck K; Breeden A; Seltzer R; VanMeter JW; Gropman AL
    Mol Genet Metab; 2014; 113(1-2):136-41. PubMed ID: 24881970
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hypocitrullinemia in expanded newborn screening by LC-MS/MS is not a reliable marker for ornithine transcarbamylase deficiency.
    Cavicchi C; Malvagia S; la Marca G; Gasperini S; Donati MA; Zammarchi E; Guerrini R; Morrone A; Pasquini E
    J Pharm Biomed Anal; 2009 Jul; 49(5):1292-5. PubMed ID: 19359120
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical and genetic analysis of five Chinese patients with urea cycle disorders.
    Zheng Z; Lin Y; Lin W; Zhu L; Jiang M; Wang W; Fu Q
    Mol Genet Genomic Med; 2020 Jul; 8(7):e1301. PubMed ID: 32410394
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficient mitochondrial import of newly synthesized ornithine transcarbamylase (OTC) and correction of secondary metabolic alterations in spf(ash) mice following gene therapy of OTC deficiency.
    Zimmer KP; Bendiks M; Mori M; Kominami E; Robinson MB; Ye X; Wilson JM
    Mol Med; 1999 Apr; 5(4):244-53. PubMed ID: 10448647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.